Chicago Equity Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $1.54M | Sell |
17,825
-5,615
| -24% | -$486K | 0.16% | 195 |
|
|
2019
Q4 | $2.52M | Sell |
23,440
-9,050
| -28% | -$973K | 0.14% | 207 |
|
|
2019
Q3 | $2.93M | Sell |
32,490
-355
| -1% | -$32K | 0.14% | 219 |
|
|
2019
Q2 | $2.77M | Sell |
32,845
-6,140
| -16% | -$518K | 0.12% | 239 |
|
|
2019
Q1 | $3.44M | Buy |
38,985
+10,740
| +38% | +$946K | 0.13% | 215 |
|
|
2018
Q4 | $2.02M | Sell |
28,245
-4,895
| -15% | -$350K | 0.08% | 335 |
|
|
2018
Q3 | $4.08M | Buy |
33,140
+24,875
| +301% | +$3.06M | 0.12% | 237 |
|
|
2018
Q2 | $812K | Sell |
8,265
-630
| -7% | -$61.9K | 0.02% | 564 |
|
|
2018
Q1 | $738K | Sell |
8,895
-26,660
| -75% | -$2.21M | 0.02% | 544 |
|
|
2017
Q4 | $2.76M | Buy |
+35,555
| New | +$2.76M | 0.08% | 307 |
|